CDNA Q3 2023 Earnings — CareDx, Inc Revenue & Financial Results | Market Cap Arena

CDNACareDx, Inc

$889M

Q3 2023 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$67M-15.3% YoY

Gross Profit

$43M63.5% margin

Operating Income

-$29M-42.8% margin

Net Income

-$23M-35.0% margin

EPS (Diluted)

$-0.43

QoQ Revenue Growth

-4.4%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$13M

Stock-Based Comp.

$13M

Balance Sheet

Total Assets

$501M

Total Liabilities

$107M

Stockholders' Equity

$394M

Cash & Equivalents

$76M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$67M	$79M	-15.3%
Gross Profit	$43M	$51M	-16.4%
Operating Income	-$29M	-$17M	-66.0%
Net Income	-$23M	-$17M	-38.6%

Revenue Segments

Service

$48M83%

Product

$10M17%

Geographic Segments

UNITED STATES

$63M94%

Europe

$2M4%

Rest Of The World

$2M2%